7-100106268-C-T
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000359593.9(AP4M1):c.1002C>T(p.Leu334=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00836 in 1,614,108 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L334L) has been classified as Likely benign.
Frequency
Consequence
ENST00000359593.9 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4M1 | NM_004722.4 | c.1002C>T | p.Leu334= | synonymous_variant | 13/15 | ENST00000359593.9 | NP_004713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4M1 | ENST00000359593.9 | c.1002C>T | p.Leu334= | synonymous_variant | 13/15 | 1 | NM_004722.4 | ENSP00000352603 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00681 AC: 1036AN: 152210Hom.: 22 Cov.: 32
GnomAD3 exomes AF: 0.0170 AC: 4275AN: 251132Hom.: 150 AF XY: 0.0148 AC XY: 2004AN XY: 135802
GnomAD4 exome AF: 0.00853 AC: 12466AN: 1461780Hom.: 207 Cov.: 33 AF XY: 0.00820 AC XY: 5963AN XY: 727196
GnomAD4 genome AF: 0.00680 AC: 1036AN: 152328Hom.: 23 Cov.: 32 AF XY: 0.00644 AC XY: 480AN XY: 74488
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 08, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hereditary spastic paraplegia 50 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 13, 2021 | - - |
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Oct 07, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at